SG49746A1 - Submicron emulsions as ocular drug delivery vehicles - Google Patents

Submicron emulsions as ocular drug delivery vehicles

Info

Publication number
SG49746A1
SG49746A1 SG1996004651A SG1996004651A SG49746A1 SG 49746 A1 SG49746 A1 SG 49746A1 SG 1996004651 A SG1996004651 A SG 1996004651A SG 1996004651 A SG1996004651 A SG 1996004651A SG 49746 A1 SG49746 A1 SG 49746A1
Authority
SG
Singapore
Prior art keywords
drug
component
drug delivery
oil
delivery vehicles
Prior art date
Application number
SG1996004651A
Other languages
English (en)
Inventor
Haim Aviv
Donron Friedman
Amir Bar-Ilan
Micha Vered
Original Assignee
Pharmos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL102984A external-priority patent/IL102984A0/xx
Priority claimed from IL103907A external-priority patent/IL103907A0/xx
Application filed by Pharmos Corp filed Critical Pharmos Corp
Publication of SG49746A1 publication Critical patent/SG49746A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG1996004651A 1992-08-28 1993-01-05 Submicron emulsions as ocular drug delivery vehicles SG49746A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL102984A IL102984A0 (en) 1992-08-28 1992-08-28 Ophthalmic compositions comprising pilocarpine
IL103907A IL103907A0 (en) 1992-11-27 1992-11-27 Ophthalmic compositions

Publications (1)

Publication Number Publication Date
SG49746A1 true SG49746A1 (en) 1998-06-15

Family

ID=26322499

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996004651A SG49746A1 (en) 1992-08-28 1993-01-05 Submicron emulsions as ocular drug delivery vehicles

Country Status (8)

Country Link
US (1) US5496811A (fr)
EP (1) EP0656779B1 (fr)
AT (1) ATE191641T1 (fr)
AU (1) AU680813B2 (fr)
CA (1) CA2142103C (fr)
DE (1) DE69328368T2 (fr)
SG (1) SG49746A1 (fr)
WO (1) WO1994005298A1 (fr)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2160681A1 (fr) * 1993-04-19 1994-10-27 Masao Takahashi Preparation d'une microemulsion renfermant une substance legerement absorbable
US5961970A (en) * 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
SE9401174D0 (sv) * 1994-04-07 1994-04-07 Astra Ab New combination
ES2094688B1 (es) * 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
DE19511322C2 (de) 1995-03-28 1999-09-02 Mann Gerhard Chem Pharm Fab Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
US5767153A (en) * 1995-06-07 1998-06-16 Insite Vision Incorporated Sustained release emulsions
DE19527132A1 (de) * 1995-07-25 1997-01-30 Laevosan Gmbh & Co Kg Ophthalmologische Ozonschutzzusammensetzung
ZA966579B (en) * 1995-08-04 1998-02-02 Wakamoto Pharma Co Ltd O/W emulsion composition for eye drops.
WO1997024933A1 (fr) * 1996-01-05 1997-07-17 Grow Green Pty. Ltd. Charge d'alimentation de proteines; compositions, procedes et dispositif de production associes
ES2118033B1 (es) * 1996-02-16 1999-07-01 Bial Ind Farmaceutica S A Formulacion farmaceutica antiinflamatoria.
US6245349B1 (en) 1996-02-23 2001-06-12 éLAN CORPORATION PLC Drug delivery compositions suitable for intravenous injection
CA2331640A1 (fr) * 1998-05-07 1999-11-11 Elan Corporation Plc Systemes d'apport de medicament de preconcentre de microemulsion et d'emulsion depourvues de solvant/cosolvant
US6241969B1 (en) 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
US8466134B1 (en) 1998-06-26 2013-06-18 Athena Neurosciences, Inc. Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
DE69912441T2 (de) 1998-08-19 2004-08-19 Skyepharma Canada Inc., Verdun Injizierbare wässerige propofoldispersionen
FR2787326B1 (fr) † 1998-12-17 2001-01-26 Oreal Nanoemulsion a base d'esters gras de glycerol, et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
AUPQ228199A0 (en) 1999-08-18 1999-09-09 Sly, Anthony William Ophthalmic fluid
US7153525B1 (en) * 2000-03-22 2006-12-26 The University Of Kentucky Research Foundation Microemulsions as precursors to solid nanoparticles
US20020013331A1 (en) 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
CA2432136A1 (fr) * 2000-12-28 2002-07-11 Kiyoshi Ebihara Preparation d'une emulsion pharmaceutique
WO2002074281A1 (fr) * 2001-03-15 2002-09-26 Novartis Ag Compositions ophtalmiques et leur utilisation
US20030165545A1 (en) * 2002-01-30 2003-09-04 Allergan, Inc. Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same
EP1480636B1 (fr) * 2002-03-01 2007-04-18 Novagali Pharma SA Systemes d'apport de medicaments auto-emulsifiants pour taxoides
EP1340497A1 (fr) * 2002-03-01 2003-09-03 Novagali Sas Systèmes d'apport de médicament auto-émulsifiant pour médicaments à faible solubilité
PE20030828A1 (es) * 2002-03-04 2003-11-04 Novartis Ag Composicion oftalmica que comprende ascomicina
US8420699B1 (en) 2002-06-19 2013-04-16 Irvine L. Dubow Composition and methods of treatment using deionized and ozonated solution
US7897642B1 (en) * 2002-06-19 2011-03-01 Dr. Irvine Dubow Compositions and methods for dry eye syndrome
AU2003291667A1 (en) * 2002-10-31 2004-06-07 Alza Corporation Pharmaceutical formulation providing an increased bioavailability of hydrophobic drugs
US6635654B1 (en) 2003-01-09 2003-10-21 Allergan, Inc. Ophthalmic compositions containing loratadine
PT1586316E (pt) 2003-01-21 2008-05-28 Senju Pharma Co Preparação líquida aquosa contendo ácido 2-amino-3-(4- bromobenzoil)fenilacético
US20040185068A1 (en) * 2003-03-18 2004-09-23 Zhi-Jian Yu Self-emulsifying compositions, methods of use and preparation
US20040191332A1 (en) * 2003-03-27 2004-09-30 Allergan, Inc. Preserved ophthalmic compositions
WO2004089357A2 (fr) * 2003-04-02 2004-10-21 Regents Of The University Of Minnesota Preparation antifongique a base de triterpene et d'huile essentielle
WO2005018608A1 (fr) * 2003-08-20 2005-03-03 Santen Pharmaceutical Co., Ltd. Systeme d'administration de produit pharmaceutique pour administrer de fins grains sous la capsule de tenon
KR101188156B1 (ko) * 2003-09-10 2012-10-05 센주 세이야꾸 가부시키가이샤 콘택트렌즈용 안과용 조성물
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
DE602005011928D1 (de) * 2004-01-20 2009-02-05 Allergan Inc Zusammensetzungen für die lokalisierte therapie des auges, vorzugsweise enthaltend triamcinolon-acetonid und hyaluronsäure
EP1611879B1 (fr) * 2004-07-02 2009-08-12 Novagali Pharma SA Utilisation des émulsions pour injection intra- et périoculaire.
ES2314354T3 (es) * 2004-11-09 2009-03-16 Novagali Pharma S.A. Emulsion de tipo aceite en agua con baja concentracion de agente cationico y potencial zeta positivo.
AU2005304035B2 (en) * 2004-11-09 2010-07-22 Santen Sas Ophthalmic oil-in-water type emulsion with stable positive zeta potential
EP1827393A4 (fr) * 2004-12-09 2012-04-18 Insys Therapeutics Inc Formulations de dronabinol stable a temperature de laboratoire
EP1676568A1 (fr) * 2004-12-30 2006-07-05 Merckle Gmbh Particules comprenant des phospholipides, procédé de préparation et utilisation comme médicament
CN101232902B (zh) * 2005-07-29 2013-04-17 参天制药株式会社 使用固态组合物的对后眼部组织的非侵袭性药物传递系统
US8097646B2 (en) * 2005-11-07 2012-01-17 Alpharx, Inc. Ophthalmic preparation containing menthyl ester of indomethacin
US9265724B2 (en) 2005-11-07 2016-02-23 Ram B. Murty Oral dosage form of tetrahydrocannabinol and a method of avoiding and/or suppressing hepatic first pass metabolism via targeted chylomicron/lipoprotein delivery
US20070142478A1 (en) * 2005-12-21 2007-06-21 Erning Xia Combination antimicrobial composition and method of use
US20070140897A1 (en) * 2005-12-21 2007-06-21 Hongna Wang Ph stable biguanide composition and method of treatment and prevention of infections
US20070141091A1 (en) * 2005-12-21 2007-06-21 Erning Xia Biguanide ointment and method of treatment and prevention of infections
US10137083B2 (en) * 2006-03-07 2018-11-27 SGN Nanopharma Inc Ophthalmic preparations
US11311477B2 (en) * 2006-03-07 2022-04-26 Sgn Nanopharma Inc. Ophthalmic preparations
WO2008035246A2 (fr) 2006-07-28 2008-03-27 Novagali Pharma Sa Compositions contenant des composés ammonium quaternaire
WO2008019146A2 (fr) * 2006-08-04 2008-02-14 Insys Therapeutics Inc. Formulations aqueuses de dronabinol
US20080132475A1 (en) * 2006-12-05 2008-06-05 Charles Gerald Connor Treatment for dry eye
JP5850602B2 (ja) * 2006-12-21 2016-02-03 サンテン・エス・エー・エス 眼科用水中油型乳剤を製造する方法
US20080161405A1 (en) * 2006-12-29 2008-07-03 Erning Xia Biguanide Composition and Method of Treatment and Prevention of Infections
WO2008120249A1 (fr) * 2007-03-30 2008-10-09 Sifi S.P.A. Produits pharmaceutiques à base de lipides polaires et non polaires pour utilisation ophtalmique
JP2010535774A (ja) * 2007-08-06 2010-11-25 インシス セラピューティクス インコーポレイテッド 経口カンナビノイド液体製剤および治療方法
JP2011502990A (ja) * 2007-11-05 2011-01-27 ボーシュ アンド ローム インコーポレイティド 薬物送達用ビヒクルとしての水非混和性物質
US20110212142A1 (en) * 2008-11-17 2011-09-01 Laila Pharmaceuticals Pvt.Ltd. Curcuminoids and its metabolites for the application in ocular diseases
US8778999B2 (en) 2009-03-05 2014-07-15 Insite Vision Incorporated Non-steroidal anti-inflammatory ophthalmic compositions
EP2437684B1 (fr) * 2009-06-03 2022-06-15 ForSight Vision5, Inc. Distribution de médicament de segment antérieur
EP2389939A1 (fr) 2010-05-28 2011-11-30 Novagali Pharma S.A. Utilisation de prostaglandines F2alpha et analogues pour la cicatrisation des lésions de la cornée et du conjonctif
CN104688687A (zh) 2009-12-03 2015-06-10 诺华股份有限公司 疫苗佐剂制备中的亲水过滤
CL2012001399A1 (es) 2009-12-03 2013-03-08 Novartis Ag Metodo para fabricar adyuvante para vacuna (emulsion aceite/agua con escualeno, polisorbato 80 y trioleato de sorbitan), que comprende (i) formar primera emulsion en homogenizador desde un contendor a otro para formar segunda emulsion, (ii) y microfluidizar primera emulsion para formar segunda emulsion.
DE102009056883B4 (de) 2009-12-03 2012-08-16 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
DE102009056884B4 (de) 2009-12-03 2021-03-18 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
EP2506834B1 (fr) 2009-12-03 2016-03-02 Novartis AG Circulation de constituants lors de l'homogénéisation et de la microfluidisation d'émulsions
FR2956320B1 (fr) * 2010-02-17 2013-12-20 Commissariat Energie Atomique Nanoemulsion pour la delivrance d'au moins deux agents d'interet
GB201009676D0 (en) 2010-06-10 2010-07-21 Glaxosmithkline Biolog Sa Novel process
CN102958368B (zh) 2010-06-25 2014-12-17 先正达参股股份有限公司 控制螨的方法
WO2012033478A1 (fr) * 2010-09-07 2012-03-15 Murty Pharmaceuticals, Inc. Forme galénique orale améliorée de tétahydrocannabinol et méthode permettant d'éviter et/ou de réprimer le métabolisme de premier passage hépatique par l'intermédiaire de l'administration ciblée de chylomicrons/lipoprotéines
BR112013024657A2 (pt) * 2011-03-25 2016-12-20 Allergan Inc antagonistas da s1p como hipotensivos oculares adjuntos
JP5989780B2 (ja) 2011-09-14 2016-09-07 フォーサイト・ビジョン５・インコーポレイテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ５，Ｉｎｃ． 眼挿入装置および方法
WO2013098841A1 (fr) * 2011-10-31 2013-07-04 Fdc Limited Nano-dispersion de médicament(s) peu soluble(s) dans l'eau
RU2652063C2 (ru) 2012-10-26 2018-04-24 Форсайт Вижн5, Инк. Офтальмологическая система для замедленного высвобождения лекарственного средства в глазу
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
WO2018212846A1 (fr) * 2017-05-19 2018-11-22 Ocugen, Inc. Compositions ophtalmiques et leurs procédés d'utilisation
US20200352987A1 (en) * 2017-08-30 2020-11-12 Tathagata DUTTA Emulsions for ophthalmic delivery of antioxidants
CN117695226A (zh) 2018-12-11 2024-03-15 迪斯拉普申实验室公司 用于递送治疗剂的组合物及其使用方法和制备方法
DE202019100257U1 (de) 2019-01-17 2019-02-20 Ledlenser GmbH & Co. KG Clip
WO2025184482A1 (fr) * 2024-02-29 2025-09-04 Telios Pharma, Inc. Méthodes et compositions pour traiter une maladie ophtalmique

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3608073A (en) * 1968-07-16 1971-09-21 Barnes Hind Pharm Inc Emulsion of pilocarpine for ophthalmic use
US4289080A (en) * 1979-07-25 1981-09-15 Celanese Corporation High-speed transplanter
DE3066859D1 (en) * 1979-10-26 1984-04-12 Smith & Nephew Ass Autoclavable emulsions
JPS62270521A (ja) * 1986-05-16 1987-11-24 Green Cross Corp:The フルルビプロフエン眼投与製剤
US4914088A (en) * 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
AU614465B2 (en) * 1989-04-05 1991-08-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
CA2052950A1 (fr) * 1990-10-10 1992-04-11 David P. Evitts Microemulsions aqueuses de tepoxalin a usage ophtalmique
US5422073A (en) * 1990-12-27 1995-06-06 Allergan, Inc. Method and composition for disinfecting contact lenses
IL98747A0 (en) * 1991-07-05 1992-07-15 Yissum Res Dev Co Ophthalmic compositions

Also Published As

Publication number Publication date
CA2142103C (fr) 2003-07-08
EP0656779A4 (fr) 1995-07-26
EP0656779B1 (fr) 2000-04-12
DE69328368D1 (de) 2000-05-18
WO1994005298A1 (fr) 1994-03-17
US5496811A (en) 1996-03-05
AU680813B2 (en) 1997-08-14
DE69328368T2 (de) 2000-08-10
AU3432593A (en) 1994-03-29
EP0656779A1 (fr) 1995-06-14
ATE191641T1 (de) 2000-04-15
CA2142103A1 (fr) 1994-03-17

Similar Documents

Publication Publication Date Title
SG49746A1 (en) Submicron emulsions as ocular drug delivery vehicles
DE69529932T2 (de) Tränendrüsenspezifische Emulsionen zur topischen Anwendung an okuläre Gewebe
DE60303854T2 (de) Nasenformulierung mit kontrollierter Freisetzung von Sexualhormonen
DE3871596T2 (de) Anwendung eines prostaglandins in mischung mit einem adrenergischen blocker zur verminderung des augen-innendruckes.
CA2193497A1 (fr) Emulsion aqueuse a liberation regulee
KR890700036A (ko) 비내 투여용 제제 및 그 제조방법
CA2132736A1 (fr) Systeme de liberation topique et transdermique au moyen de spheres d'huile submicroniques
DE69301920T2 (de) Arzneimittel zur transmucosalen verabreichung von peptiden
EP0788346A4 (fr) Systemes d'administration de medicaments emulsionnes
DE69008729T2 (de) Verfahren zur herstellung einer öl-in-wasser-emulsion eines wirkstoffes.
WO1999056727A3 (fr) Systemes d'apport de medicament de preconcentre de microemulsion et d'emulsion depourvues de solvant/cosolvant
ES8708185A1 (es) Un procedimiento para la preparacion de una emulsion de lipidos.
EP0521799A1 (fr) Compositions ophtalmiques
BG104558A (en) Topical ophthalmic preparations containing immunosuppressive agents
DE2714065A1 (de) Instillationszubereitung
EP0473810B1 (fr) Préparations à usage externe contenant de l'eau et du propionate de déprodone
AU621763B2 (en) Stable tretinoin emulsified cream formulations
DD274562A5 (de) Verfahren zur herstellung von pharmazeutischen zubereitungen
EP0308460B1 (fr) Composition pour le traitement topique du glaucome ou de l'hypertension oculaire
DE69228686T2 (de) Topisch anzuwendendes arzneimittel enthaltend penciclovir
JP4521899B2 (ja) クロタミトン含有皮膚外用液剤
DE69825322T2 (de) Topische carbamazepin-formulierungen und deren verwendung
Erkin et al. Penetration of amikacin into aqueous humor of rabbits
DE9421079U1 (de) Arzneiliche Formulierung mit antiviraler Wirkung, insbesondere gegen Herpes-Viren
ZA9369B (en) Submicron emulsions as ocular drug delivery vehicles.